Grundmann R, von Lehndorff C
Langenbecks Arch Chir. 1986;367(4):235-46. doi: 10.1007/BF01263404.
In a prospectively randomised study (n = 161) we examined whether postoperative human albumin administration is justified in intensive care patients whenever the colloid osmotic pressure (COP) decreases below 26 cm H2O. Postoperative complication rates did not increase in the control group, although only 22% of these patients received albumin as compared to 100% in the therapy group. A decline of the COP below extreme values (even under 20 cm H2O) was compatible with survival. This study established only one indication for postoperative human albumin therapy: acute volume substitution in patients on dialysis. Consequently, in the second half year of this study only 3 of 49 patients of the control group received human albumin therapy.
在一项前瞻性随机研究(n = 161)中,我们研究了对于重症监护患者,当胶体渗透压(COP)降至26 cm H₂O以下时,术后给予人血白蛋白是否合理。对照组的术后并发症发生率并未增加,尽管这些患者中只有22%接受了白蛋白治疗,而治疗组这一比例为100%。COP降至极低值(甚至低于20 cm H₂O)与患者存活是相符的。这项研究仅确定了术后人血白蛋白治疗的一个指征:透析患者的急性容量替代。因此,在本研究的下半年,对照组49例患者中只有3例接受了人血白蛋白治疗。